Sanjivani Paranteral Limited (BOM:531569)

Market Cap	2.83B
Revenue (ttm)	689.20M
Net Income (ttm)	74.57M
Shares Out	12.28M
EPS (ttm)	5.98
PE Ratio	38.45
Forward PE	n/a
Dividend	0.50 (0.22%)
Ex-Dividend Date	Sep 19, 2025

Volume	6,108
Average Volume	8,781
Open	221.90
Previous Close	226.40
Day's Range	221.90 - 235.00
52-Week Range	170.00 - 396.95
Beta	-0.89
RSI	60.32
Earnings Date	Nov 14, 2025

About Sanjivani Paranteral

Sanjivani Paranteral Limited operates as a pharmaceutical company in India. The company manufactures pharmaceutical products in the form of oral solids, small volume parenteral, and sterile powder formulations for various therapeutic areas, including central nervous system, cardiovascular system, antibiotics, gastroenterological, anti-diabetics, and anti-allergic. It also offers soft gels, such as multivitamins; topicals comprising corticosteroids, antiseptics, NSAIDs, and anti-bacterial; nasal sprays; liquid and dry powder injections covering ...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 40
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 531569

Financial Performance

In 2024, Sanjivani Paranteral's revenue was 700.99 million, an increase of 28.83% compared to the previous year's 544.11 million. Earnings were 80.97 million, an increase of 31.34%.